A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2674315
A combination therapy comprising an immunotherapy based on a tumour antigen or an immunological derivative thereof, and at least one other treatment for cancer such as chemotherapy, radiotherapy and/or surgery.
La présente invention concerne une polythérapie impliquant une immunothérapie basée sur un antigène tumoral ou un dérivé immunologique de celui-ci, et au moins un autre traitement du cancer, tel qu'une chimiothérapie, une radiothérapie et/ou une intervention chirurgicale.
Brichard Vincent
Gerard Catherine Marie Ghislaine
Lehmann Frederic Francois Eugene
Louahed Jamila
Glaxosmithkline Biologicals Sa
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of mage a3-protein d fusion antigen in immunotherapy... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of mage a3-protein d fusion antigen in immunotherapy..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mage a3-protein d fusion antigen in immunotherapy... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1808635